Featured Research

from universities, journals, and other organizations

Novel test following prostate surgery could detect cancer recurrence earlier

Date:
October 1, 2010
Source:
American Association for Cancer Research
Summary:
A new test could reliably detect early increases in prostate specific antigen levels -- a biomarker commonly used to measure the recurrence of prostate cancer -- in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes.

A new test could reliably detect early increases in prostate specific antigen (PSA) levels -- a biomarker commonly used to measure the recurrence of prostate cancer -- in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes.

Data measuring the efficacy of this new test were presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

"AccuPSA is a simple blood test that can tell a physician important information about prostate specific antigen levels after radical prostatectomy," said David Wilson, Ph.D., senior director of product development at Quanterix Corporation, the manufacturer of the test. "AccuPSA has the potential to eliminate unnecessary treatments and enable earlier detection of recurrence, which may lead to earlier treatment, better outcomes and have a positive impact on health care costs."

After undergoing radical prostatectomy, many men remain at a significant risk for cancer recurrence. Because of this, patients are monitored very closely for rapid increases in PSA, which may signal cancer recurrence.

Standard PSA tests are primarily used to screen asymptomatic men for prostate cancer. However, once the prostate is surgically removed, PSA levels are usually undetectable using standard tests, according to Wilson. AccuPSA, which uses Quanterix's proprietary Single Molecule Array (SiMoA™) technology, is able to detect PSA with unprecedented sensitivity, and at much lower levels than standard PSA tests because it can selectively capture and measure individual PSA molecules.

To determine the accuracy of the novel blood test, PSA levels were measured in blood taken from 60 men who had undergone radical prostatectomy. These specimens had all been categorized as being below the detection limit of standard PSA tests. However, using AccuPSA, researchers were able to measure PSA in all of the samples.

"After radical prostatectomy, many important questions remain for the physician and the patient," Wilson said. "AccuPSA is designed to help the physician and patients to become better informed by measuring PSA after radical prostatectomy and establishing if the cancer is gone or has metastasized or recurred."

The next step in this research is to conduct a large retrospective clinical study to formally establish the utility of this test.

"We hope to be able to establish with our clinical study that nadir values -- the lowest value of PSA that occurs post-surgery -- are predictive of prostate cancer recurrence," he said. "What this might mean for a post-radical prostatectomy patient is that a nadir PSA level below an established threshold could indicate if the patient is effectively considered 'cured.'"


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

American Association for Cancer Research. "Novel test following prostate surgery could detect cancer recurrence earlier." ScienceDaily. ScienceDaily, 1 October 2010. <www.sciencedaily.com/releases/2010/09/100929163407.htm>.
American Association for Cancer Research. (2010, October 1). Novel test following prostate surgery could detect cancer recurrence earlier. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2010/09/100929163407.htm
American Association for Cancer Research. "Novel test following prostate surgery could detect cancer recurrence earlier." ScienceDaily. www.sciencedaily.com/releases/2010/09/100929163407.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins